$358.24
-4.20-1.16%
At close: Jul 17, 5:00 PM EST
$358.24
N/A
After Hours: Jul 17, 4:03 PM EST
West Pharmaceutical Services Inc Stock Guidance
WSTNYSE
West Pharmaceutical Servs (WST) last issued guidance on April 23, 2026 for Q2 2026. The company guided earnings per share in the range of $2.05 - $2.12, compared to a consensus EPS estimate of $2.00. West Pharmaceutical Servs also guided revenue in the range of $830.00M - $850.00M for the period.
Compared to prior guidance, West Pharmaceutical Servs lowered its revenue forecast from a prior range of $3.29B - $3.35B.
West Pharmaceutical Servs has issued 17 guidance updates between July 28, 2022 and April 23, 2026. During this period, the company raised its outlook 12 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Apr 23, 2026
Guidance Period
Q2 2026
EPS Guidance Range
$2.05 - $2.12
Revenue Guidance Range
$830.00M - $850.00M
West Pharmaceutical Servs Guidance History
Review all historical guidance issued by West Pharmaceutical Servs, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for West Pharmaceutical Servs (WST)?
The most recent guidance for West Pharmaceutical Servs (WST) was reported on April 23, 2026 for Q2 2026. The company provided earnings per share guidance in the range of $2.05 to $2.12, compared to the estimated EPS of $2.00. Additionally, West Pharmaceutical Servs forecasted revenue between $830.00M and $850.00M for the period.
What EPS range did West Pharmaceutical Servs (WST) guide for?
West Pharmaceutical Servs (WST) guided EPS in the range of $2.05 to $2.12 for Q2 2026. The consensus analyst EPS estimate is $2.00.
What revenue range did West Pharmaceutical Servs (WST) guide for?
West Pharmaceutical Servs (WST) guided revenue in the range of $830.00M to $850.00M for Q2 2026.
Did West Pharmaceutical Servs (WST) raise or lower guidance?
West Pharmaceutical Servs (WST) lowered its revenue guidance from a prior range of $3.29B - $3.35B to $830.00M - $850.00M for Q2 2026.
When did West Pharmaceutical Servs (WST) last issue guidance?
West Pharmaceutical Servs (WST) last issued guidance on April 23, 2026 for Q2 2026.
